involving the general 1,4-addition of nucleophiles into dia-
zoacetoacetate enones 1(DAAEs,Scheme1).Inthisway, the
bulk of the organic framework can be conveniently installed
to access 1 via a Wittig olefination reaction, and 1,4-addition
reactions of a variety of nucleophiles would facilitate con-
struction of CꢀC and CꢀN bonds at C(5) using 1 as a
modular synthetic platform.
Related tetralin natural products, exemplified by trihy-
droxycalamenene 4, constitute a broad class of biologically
active natural products.4,5 On the other hand, if indoles or
pyrroles are added, the electron-rich heterocycle present in
2 is expected to react preferentially to allow access to
dihydrocarbazoles 5 and dihydroindoles 7. These hetero-
cycles are present in a variety of biologically active sub-
stances including the natural products angustilodine (6)6
and stenine (8).7 Finally, the reactions of 2 with amines
would allow expedient access to pyrrolidinones 9 of which
a large number of biologically active substances belong
and in this case is exemplified by the natural product
condonopsinol (10).8 The proposed route to these natural
product-like scaffolds represents an efficient and atom-
economical approach in that both steps are catalyst con-
trolled; exceptfor dinitrogen, all of the atoms present in the
starting materials are maintained through the sequence.
Only a few examples of diazoacetoacetate enones 1 in
dinitrogen extrusion reactions have been reported;9 how-
ever, their reactivity as electrophiles has not been explored.
Since a general method for synthesizing DAAEs 1 was not
available, we set out to develop a convenient one-pot
protocol for the general prepartion of 1 (Table 1). Com-
mercially available Wittig reagent 11 was chosen as the
starting material,10 and treatment of 11 with a variety of
aldehydes in the presence of NaH effected olefination to
provide enones that were not isolated. Rather, upon
completion of the olefination reaction, buffered NEt3
(3:1 withAcOH) and the diazo transfer agent p-acetamido-
benzenesulfonyl azide (p-ABSA)11 were added to the reac-
tion mixture to afford DAAE 1 as mixtures (1:1 to 3:1) of
(E) and (Z)-isomers. Isomerization of the (Z)-enones to the
more thermodyamically favored (E)-enones was promoted
by the addition of DABCO in catalytic amounts to the
initial olefination reaction. This two-step/one-pot proce-
dure cleanly provided (E)-diazoacetoacetate enones 1 in
64ꢀ75% yield for a series of nine different derivatives of 1
ranging in group electronegativities and subsitution.
Scheme 1. Natural Product-like Scaffolds Derived from
Nucleophilic Additions to Diazoacetoacetate Enones (DAAEs)
We envisioned DAAE 1 as being a general template for
the construction of a variety of important, biologically
relevant carbo- and heterocyclic ring systems byemploying
selective rhodium-catalyzed ring forming reactions on the
1,4-addition products 2 (Scheme 1). Therefore, the fate of
adduct 2 in catalytic dinitrogen extrusion reactions would
depend solely on the nucleophile that is chosen to function-
alize 1, since the intermediate metal carbene formed from
diazo decomposition of 2 would be expected to react with
the newly installed RZ functionality or the aromatic ring
native to 1 (R = Ar) depending on which is more electron
rich. For example, the adduct resulting from reactions with
silyl enol ethers (RZ = CH2COR0), when exposed to a
rhodium catalyst, would give β-tetralone derivatives 3 by
Buchner-type reactions onto the appended aromatic ring.
The electrophilic behavior displayed by the library of
DAAEs 1 as novel Michael acceptors (Scheme 2) was
explored. Mukaiyama-Michael additions of enone 1a with
silyl enol ethers 12aꢀc were first chosen to test the pro-
posed electrophilic behavior of DAAE 1. A variety of
metal triflate salts was screened, and Sc(OTf)3 was found
to provide the highest reactivity and overall yields in
CH2Cl2 as the solvent. For the Mukaiyama-type reactions,
˚
theuseof4 A molecularsievesallowed thesereactionstobe
performed in a moisture-free environment that was
(6) Kam, T.; Choo, Y. Helv. Chim. Acta 2004, 87, 366–369.
(7) Uyeo, S.; Irie, H.; Harada, H. Chem. Pharm. Bull. 1967, 15, 768–
770.
(8) Ishida, S.; Okasaka, M.; Ramos, F.; Kashiwada, Y.; Takaishi, Y.;
Kodzhimatov, O. K.; Ashurmetov, O. J. Nat. Med. 2008, 62, 236–238.
(9) (a) Collomb, D.; Doutheau, A. Tetrahedron Lett. 1997, 38, 1397–
1398. (b) Taylor, E. C.; Davies, H. M. L. Tetrahedron Lett. 1983, 24,
5453–5456. (c) Deng, G.; Xu, B.; Wang, J. Tetrahedron 2005, 61, 10811–
10817.
(10) Pietrusiewicz, K. M.; Monkiewicz, J.; Bodalski, R. J. Org. Chem.
1983, 48, 788–790.
(11) Baum, J. S.; Shook, D. A.; Davies, H. M. L. Synth. Commun.
(4) Silva, G. H.; Teles, H. L.; Zanardi, L. M.; Young, M. C. M.;
Eberlin, M. N.; Hadad, R.; Pfenning, L. H.; Costa-Neto, C. M.; Castro-
ꢀ
Gamboa, I.; Bolzani, V. S.; Araujo, A. R. Phytochemistry 2006, 67,
1964–1969.
(5) (a) Bianco, G. G.; Ferraz, H. M. C.; Costa, A. M.; Costa-Lotufo,
L. V.; PesCsoa, C.; de Moraes, M. O.; Schrems, M. G.; Pfaltz, A.; Silva,
L. F. J. Org. Chem. 2009, 74, 2561–2566. (b) Silva, L. F.; Siqueira, F. A.;
Pedrozo, E. C.; Vieira, F. Y. M.; Doriguetto, A. C. Org. Lett. 2007, 9,
1433–1436.
1987, 17, 1709–1716.
B
Org. Lett., Vol. XX, No. XX, XXXX